Literature DB >> 15936624

The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy.

Ferdinand S Leya1, Dinesh Arab, Dominique Joyal, Krystyna M Shioura, Bruce E Lewis, Lowell H Steen, Leslie Cho.   

Abstract

OBJECTIVES: We sought to determine the usefulness of brain natriuretic peptide (BNP) measurements to differentiate constrictive pericarditis (CP) from restrictive cardiomyopathy (RCMP).
BACKGROUND: The differentiation of CP from RCMP may be clinically difficult and often requires hemodynamic assessment. No laboratory marker has been shown to differentiate the two conditions.
METHODS: We measured BNP levels in 11 patients suspected of having either CP or RCMP. All patients had hemodynamic assessment the day of BNP measurements.
RESULTS: Six patients had CP and five patients had RCMP based on established hemodynamic criteria. Both CP and RCMP patients had similar elevation in intracardiac pressures. Despite similar pressures, the mean plasma BNP levels were significantly higher in RCMP compared to CP (825.8 +/- 172.2 pg/ml vs. 128.0 +/- 52.7 pg/ml, p < 0.001, respectively).
CONCLUSIONS: The BNP levels are significantly elevated in RCMP compared to CP patients; BNP may prove to be a useful noninvasive marker for the differentiation of the two conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15936624     DOI: 10.1016/j.jacc.2005.03.050

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  28 in total

1.  [A rare cause of right heart failure].

Authors:  Rolf Wachter; Gerd Hasenfuss
Journal:  Med Klin (Munich)       Date:  2010-04

2.  Pericardial disease: what the general cardiologist needs to know.

Authors:  Emma L Ivens; Bradley I Munt; Robert R Moss
Journal:  Heart       Date:  2007-08       Impact factor: 5.994

3.  Management of constrictive pericarditis in the 21st century.

Authors:  Geoffrey C Clare; Richard W Troughton
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12

Review 4.  Extracardiac medical and neuromuscular implications in restrictive cardiomyopathy.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Cardiol       Date:  2007-08       Impact factor: 2.882

5.  Effusive reasoning.

Authors:  Brandon Erickson; Gurpreet Dhaliwal; Mark C Henderson; Ezra Amsterdam; Joseph Rencic
Journal:  J Gen Intern Med       Date:  2011-07-15       Impact factor: 5.128

Review 6.  Advances in the differentiation of constrictive pericarditis and restrictive cardiomyopathy.

Authors:  D R Zwas; I Gotsman; D Admon; A Keren
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

7.  NT pro B type natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy.

Authors:  Neeraj Parakh; Sameer Mehrotra; Sandeep Seth; S Ramakrishnan; Shyam S Kothari; Balram Bhargava; V K Bahl
Journal:  Indian Heart J       Date:  2015-03-13

Review 8.  Interpretation and use of natriuretic peptides in non-congestive heart failure settings.

Authors:  Shih-Hung Tsai; Yen-Yue Lin; Shi-Jye Chu; Ching-Wang Hsu; Shu-Meng Cheng
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

9.  Hiding in plain sight; constrictive pericarditis.

Authors:  Jonathan Ryan Schroeder; Hernan Osorno; Robert Chait; Andrew Fischer
Journal:  BMJ Case Rep       Date:  2013-02-27

10.  Characteristics of acute congestive heart failure with normal ejection fraction and less elevated B-type natriuretic peptide.

Authors:  Ken Shimamoto; Natsuha Koike; Kiyoko Mizuochi; Miho Honma; Yufuko Kasai; Akiko Sakai; Etsuko Fujita; Masatoshi Kawana
Journal:  BMC Cardiovasc Disord       Date:  2009-01-24       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.